Basilea gibt Clinical Trial Collaboration and Supply Agreement mit Eli Lilly and Company für Ramucirumab für die laufende FIDES-03-Studie mit Derazantinib bei Magenkrebs bekannt

NEXT STORY
Fitness Tracker Market to Exhibit a CAGR of 15.2% and Reach USD 91.98 Billion by 2027; High Demand for Wearables Devices to Create Sales Opportunities, states Fortune Business Insights™
PREV STORY
North Americaportable oxygen concentratorsmarket is expected to reach US$ 1,315.42 million by 2027 from US$ 682.73 million in 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 28, 2018

SOUTH JORDAN, Utah, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), ...

author_avatar
NASDAQ Market News

VigiLanz Integrates Infectious Disease Content from Sanford Guide

MINNEAPOLIS, MN--(Marketwired - Nov 29, 2017) - VigiLanz, a digital healthcare intelligence firm, announced ...

author_avatar
NASDAQ Market News

Immune Design Reports First Quarter 2018 Financial Results and Provides Corporate Update

The higher dose of CMB305 was deemed safe and cleared for the pivotal Phase 3The ...

author_avatar
NASDAQ Market News